![William Matthews](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Matthews
Keine laufenden Positionen mehr
Profil
William Matthews was a Director at Sure Laboratories Ltd.
Ehemalige bekannte Positionen von William Matthews
Unternehmen | Position | Ende |
---|---|---|
Sure Laboratories Ltd.
![]() Sure Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Sure Laboratories is an independent clinical cytogenetic service laboratory providing dedicated microarray based comparative genomic hybridization (arrayCGH) screening for detection of copy number imbalance and aneuploidy. It is established by BlueGnome to ensure fast turnaround and high quality results, maintaining a clear workflow and SOPs for the sole purpose of delivering the highest clinical standards. It offers services, such as PGS screening of single cells for aneuploidy, unbalanced translocations associated with repeated IVF failure and recurrent miscarriage or congenital anomalies where structural chromosomal abnormalities are suspected. The company was founded in 2010 and is headquartered in Cambridge, GB | Direktor/Vorstandsmitglied | 09.01.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sure Laboratories Ltd.
![]() Sure Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Sure Laboratories is an independent clinical cytogenetic service laboratory providing dedicated microarray based comparative genomic hybridization (arrayCGH) screening for detection of copy number imbalance and aneuploidy. It is established by BlueGnome to ensure fast turnaround and high quality results, maintaining a clear workflow and SOPs for the sole purpose of delivering the highest clinical standards. It offers services, such as PGS screening of single cells for aneuploidy, unbalanced translocations associated with repeated IVF failure and recurrent miscarriage or congenital anomalies where structural chromosomal abnormalities are suspected. The company was founded in 2010 and is headquartered in Cambridge, GB | Commercial Services |